Covered recipient · General Payments record
THOMAS KINCADE
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$2,698.40
- Reported across 194 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $344.10 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $133.66 | 9 |
| Xeris Pharmaceuticals, Inc. | $58.38 | 4 |
| Dompe US, Inc. | $51.91 | 3 |
| Astellas Pharma US Inc | $34.71 | 2 |
| Bausch & Lomb Americas Inc. | $30.19 | 2 |
| Tarsus Pharmaceuticals, Inc. | $18.21 | 1 |
| Alcon Laboratories Inc | $17.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.17 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104076940 | CMS |
| ABBVIE INC. | $13.60 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104076942 | CMS |
| ABBVIE INC. | $16.94 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104076944 | CMS |
| ABBVIE INC. | $14.52 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104076946 | CMS |
| ABBVIE INC. | $14.17 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104076948 | CMS |
| ABBVIE INC. | $15.45 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104076950 | CMS |
| ABBVIE INC. | $16.47 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104076952 | CMS |
| ABBVIE INC. | $14.17 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104076954 | CMS |
| ABBVIE INC. | $14.17 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104076956 | CMS |
| Alcon Vision LLC | $17.04 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110701516 | CMS |
| Astellas Pharma US Inc | $14.40 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139451012 | CMS |
| Astellas Pharma US Inc | $20.31 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139451422 | CMS |
| Bausch & Lomb Americas Inc. | $13.22 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140459036 | CMS |
| Bausch & Lomb Americas Inc. | $16.97 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140459038 | CMS |
| Dompe US, Inc. | $16.46 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417197 | CMS |
| Dompe US, Inc. | $16.97 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417199 | CMS |
| Dompe US, Inc. | $18.48 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151417201 | CMS |
| Tarsus Pharmaceuticals, Inc. | $18.21 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139108283 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.53 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144615781 | CMS |
| Xeris Pharmaceuticals, Inc. | $15.31 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144615783 | CMS |
| Xeris Pharmaceuticals, Inc. | $13.17 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144615785 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.37 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144615787 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.